Commentary

Pens [editorial]

Cutis. 2009 December;84(6):291
By
Silverberg NB
Author and Disclosure Information

No abstract available.
PDF Download

 

Recommended Reading

Dx of Stage III Melanomas Likely To Rise in 2010: New AJCC Staging Takes Effect Next Year
MDedge Dermatology
Fibroblast Injectable Gets Mixed Panel Review
MDedge Dermatology
TNF Blocker Risk-Benefit Analysis Proves Favorable
MDedge Dermatology
Ustekinumab Approved With Safety Requirement
MDedge Dermatology
Antiangiogenesis Offers New Tactic for Inflammatory Disease
MDedge Dermatology
Ustekinumab Found to Help Improve Sexual Function in Psoriasis Patients
MDedge Dermatology
Your Friendly Neighborhood Dermatologist
MDedge Dermatology
Mycophenolate Mofetil May Reduce SCC Risk After Transplant
MDedge Dermatology
Agent Targeting BRAF Mutations Shows Promise
MDedge Dermatology
Make the Diagnosis
MDedge Dermatology